PortfoliosLab logoPortfoliosLab logo
OSCR vs. WGS
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

OSCR vs. WGS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Oscar Health, Inc. (OSCR) and GeneDx Holdings Corp. (WGS). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

OSCR vs. WGS - Yearly Performance Comparison


2026 (YTD)20252024202320222021
OSCR
Oscar Health, Inc.
-20.18%6.92%46.89%271.95%-68.66%-77.44%
WGS
GeneDx Holdings Corp.
-50.62%69.22%2,694.91%-68.41%-94.09%-75.48%

Fundamentals

Market Cap

OSCR:

$3.25B

WGS:

$1.73B

EPS

OSCR:

-$1.64

WGS:

-$0.74

PS Ratio

OSCR:

0.27

WGS:

4.28

PB Ratio

OSCR:

3.32

WGS:

5.60

Total Revenue (TTM)

OSCR:

$11.70B

WGS:

$427.54M

Gross Profit (TTM)

OSCR:

$8.90B

WGS:

$298.17M

EBITDA (TTM)

OSCR:

-$390.98M

WGS:

-$13.08M

Returns By Period

In the year-to-date period, OSCR achieves a -20.18% return, which is significantly higher than WGS's -50.62% return.


OSCR

1D
5.71%
1M
-15.91%
YTD
-20.18%
6M
-39.41%
1Y
-12.51%
3Y*
20.59%
5Y*
-15.08%
10Y*

WGS

1D
7.73%
1M
-19.43%
YTD
-50.62%
6M
-40.39%
1Y
-27.49%
3Y*
74.70%
5Y*
-34.98%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

OSCR vs. WGS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OSCR
OSCR Risk / Return Rank: 3636
Overall Rank
OSCR Sharpe Ratio Rank: 3535
Sharpe Ratio Rank
OSCR Sortino Ratio Rank: 3939
Sortino Ratio Rank
OSCR Omega Ratio Rank: 3838
Omega Ratio Rank
OSCR Calmar Ratio Rank: 3434
Calmar Ratio Rank
OSCR Martin Ratio Rank: 3535
Martin Ratio Rank

WGS
WGS Risk / Return Rank: 2929
Overall Rank
WGS Sharpe Ratio Rank: 2727
Sharpe Ratio Rank
WGS Sortino Ratio Rank: 3232
Sortino Ratio Rank
WGS Omega Ratio Rank: 3232
Omega Ratio Rank
WGS Calmar Ratio Rank: 2727
Calmar Ratio Rank
WGS Martin Ratio Rank: 2424
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

OSCR vs. WGS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Oscar Health, Inc. (OSCR) and GeneDx Holdings Corp. (WGS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


OSCRWGSDifference

Sharpe ratio

Return per unit of total volatility

-0.16

-0.34

+0.18

Sortino ratio

Return per unit of downside risk

0.36

0.07

+0.29

Omega ratio

Gain probability vs. loss probability

1.04

1.01

+0.03

Calmar ratio

Return relative to maximum drawdown

-0.27

-0.46

+0.19

Martin ratio

Return relative to average drawdown

-0.52

-1.00

+0.49

OSCR vs. WGS - Sharpe Ratio Comparison

The current OSCR Sharpe Ratio is -0.16, which is higher than the WGS Sharpe Ratio of -0.34. The chart below compares the historical Sharpe Ratios of OSCR and WGS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


OSCRWGSDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.16

-0.34

+0.18

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.19

-0.33

+0.14

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.25

-0.24

0.00

Correlation

The correlation between OSCR and WGS is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

OSCR vs. WGS - Dividend Comparison

Neither OSCR nor WGS has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

OSCR vs. WGS - Drawdown Comparison

The maximum OSCR drawdown since its inception was -94.15%, smaller than the maximum WGS drawdown of -99.85%. Use the drawdown chart below to compare losses from any high point for OSCR and WGS.


Loading graphics...

Drawdown Indicators


OSCRWGSDifference

Max Drawdown

Largest peak-to-trough decline

-94.15%

-99.85%

+5.70%

Max Drawdown (1Y)

Largest decline over 1 year

-51.71%

-65.92%

+14.21%

Max Drawdown (5Y)

Largest decline over 5 years

-92.65%

-99.78%

+7.13%

Current Drawdown

Current decline from peak

-68.81%

-92.46%

+23.65%

Average Drawdown

Average peak-to-trough decline

-65.77%

-83.03%

+17.26%

Ulcer Index

Depth and duration of drawdowns from previous peaks

26.52%

30.23%

-3.71%

Volatility

OSCR vs. WGS - Volatility Comparison

The current volatility for Oscar Health, Inc. (OSCR) is 17.30%, while GeneDx Holdings Corp. (WGS) has a volatility of 25.28%. This indicates that OSCR experiences smaller price fluctuations and is considered to be less risky than WGS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


OSCRWGSDifference

Volatility (1M)

Calculated over the trailing 1-month period

17.30%

25.28%

-7.98%

Volatility (6M)

Calculated over the trailing 6-month period

52.12%

47.05%

+5.07%

Volatility (1Y)

Calculated over the trailing 1-year period

80.55%

81.64%

-1.09%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

80.16%

107.43%

-27.27%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

80.08%

106.41%

-26.33%

Financials

OSCR vs. WGS - Financials Comparison

This section allows you to compare key financial metrics between Oscar Health, Inc. and GeneDx Holdings Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B2.00B2.50B3.00B3.50BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
2.81B
120.99M
(OSCR) Total Revenue
(WGS) Total Revenue
Values in USD except per share items

OSCR vs. WGS - Profitability Comparison

The chart below illustrates the profitability comparison between Oscar Health, Inc. and GeneDx Holdings Corp. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-100.0%-50.0%0.0%50.0%100.0%AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober0
69.7%
Portfolio components
OSCR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Oscar Health, Inc. reported a gross profit of 0.00 and revenue of 2.81B. Therefore, the gross margin over that period was 0.0%.

WGS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, GeneDx Holdings Corp. reported a gross profit of 84.27M and revenue of 120.99M. Therefore, the gross margin over that period was 69.7%.

OSCR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Oscar Health, Inc. reported an operating income of -333.75M and revenue of 2.81B, resulting in an operating margin of -11.9%.

WGS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, GeneDx Holdings Corp. reported an operating income of -14.24M and revenue of 120.99M, resulting in an operating margin of -11.8%.

OSCR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Oscar Health, Inc. reported a net income of -352.61M and revenue of 2.81B, resulting in a net margin of -12.6%.

WGS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, GeneDx Holdings Corp. reported a net income of -17.67M and revenue of 120.99M, resulting in a net margin of -14.6%.